Osteoarthritis of Knee

1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Stempeutics Research
Stempeutics ResearchIndia - Bangalore
1 program
1
Ex- vivo cultured adult allogeneic MSCsPhase 21 trial
Active Trials
NCT01453738CompletedEst. Nov 2014
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Genicular nerve pulse radiofrequencyN/A1 trial
Active Trials
NCT06894147Active Not RecruitingEst. May 2025
IBSA Institut Biochimique
IBSA Institut BiochimiqueSwitzerland - Lugano-Pazzallo
1 program
SinovialN/A1 trial
Active Trials
NCT06652893CompletedEst. Nov 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Stempeutics ResearchEx- vivo cultured adult allogeneic MSCs
City TherapeuticsGenicular nerve pulse radiofrequency
IBSA Institut BiochimiqueSinovial

Clinical Trials (3)

NCT01453738Stempeutics ResearchEx- vivo cultured adult allogeneic MSCs

Allogeneic Mesenchymal Stem Cells in Osteoarthritis

Start: Nov 2011Est. completion: Nov 2014
Phase 2Completed
NCT06894147City TherapeuticsGenicular nerve pulse radiofrequency

Genicular Radiofrequency Ablation Versus Pulsed Radiofrequency

Start: Apr 2024Est. completion: May 2025
N/AActive Not Recruiting

Efficacy and Safety of Sinovial®HL Single Injection in the Knee Osteoarthritis

Start: Oct 2021Est. completion: Nov 2022
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space